Need Help?
No Article Versions Notes Found
Cite
Bebb, D.G.; Agulnik, J.; Albadine, R.; Banerji, S.; Bigras, G.; Butts, C.; Couture, C.; Cutz, J.C.; Desmeules, P.; Ionescu, D.N.; et al. Crizotinib Inhibition of ROS1-Positive Tumours in Advanced Non-Small-Cell Lung Cancer: A Canadian Perspective. Curr. Oncol. 2019, 26, 551-557. https://doi.org/10.3747/co.26.5137
Bebb DG, Agulnik J, Albadine R, Banerji S, Bigras G, Butts C, Couture C, Cutz JC, Desmeules P, Ionescu DN, et al. Crizotinib Inhibition of ROS1-Positive Tumours in Advanced Non-Small-Cell Lung Cancer: A Canadian Perspective. Current Oncology. 2019; 26(4):551-557. https://doi.org/10.3747/co.26.5137
Chicago/Turabian StyleBebb, D.G., J. Agulnik, R. Albadine, S. Banerji, G. Bigras, C. Butts, C. Couture, J.C. Cutz, P. Desmeules, D.N. Ionescu, and et al. 2019. "Crizotinib Inhibition of ROS1-Positive Tumours in Advanced Non-Small-Cell Lung Cancer: A Canadian Perspective" Current Oncology 26, no. 4: 551-557. https://doi.org/10.3747/co.26.5137
APA StyleBebb, D. G., Agulnik, J., Albadine, R., Banerji, S., Bigras, G., Butts, C., Couture, C., Cutz, J. C., Desmeules, P., Ionescu, D. N., Leighl, N. B., Melosky, B., Morzycki, W., Rashid-Kolvear, F., Sekhon, H. S., Smith, A. C., Stockley, T. L., Torlakovic, E., Xu, Z., & Tsao, M. S. (2019). Crizotinib Inhibition of ROS1-Positive Tumours in Advanced Non-Small-Cell Lung Cancer: A Canadian Perspective. Current Oncology, 26(4), 551-557. https://doi.org/10.3747/co.26.5137
